Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 21,021 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Stress
Interventions: Corporate Athlete® Resilience; Behavioral
Lead sponsor: Johnson & Johnson Health and Wellness Solutions, Inc.; Industry
Eligibility: 18 Years to 110 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Crohn's Disease
Interventions: 4-Aminosalicylic acid, PASER placebo granules; Drug
Lead sponsor: Jacobus Pharmaceutical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 3
States / cities: Chicago, Illinois • New York, New York • Charlotte, North Carolina

Conditions: Cognitive Impairment
Interventions: Phenytoin 200 mg capsule, Megestrol 800 mg liquid, Phenytoin-matched Placebo capsule, Megestrol-matched liquid Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Pain
Interventions: survey; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 110 Years
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: ACL Tear
Interventions: Mental Skills Coaching; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 25 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Chronic Kidney Disease, End-Stage Renal Disease
Interventions: House Call, Peer Mentorship; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts • Charleston, South Carolina

Conditions: Hearing Loss, Mild Cognitive Impairment, Alzheimer Disease and Related Dementias (ADRD)
Interventions: Over the counter hearing aid, Communication Strategies Information/Counseling; Device · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Evanston, Illinois • La Crosse, Wisconsin • Madison, Wisconsin

Conditions: Radiculopathy
Interventions: Lenalidomide (CC-5013); Drug
Lead sponsor: Celgene Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 23
States / cities: Phoenix, Arizona • Tucson, Arizona • Loma Linda, California + 20 more

Conditions: Degenerative Joint Disease, Osteoarthritis
Interventions: EACA, Placebo arm; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: LGBTQ, Racial Disparities, Family Relationships, Minority Stress, Depression, Anxiety, Drug Use, Teen Dating Violence, Sexual Risk Reduction
Interventions: Adapted Lakota Family Acceptance Program; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Pine Ridge, South Dakota • Rapid City, South Dakota

Conditions: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Glaucoma
Interventions: Behavioral Activation, Supportive Therapy; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Skin Manifestations
Interventions: metronidazole 1% gel, azelaic acid 15% gel; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Carrollton, Texas

Conditions: Sepsis
Interventions: Observation; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prostate Cancer
Interventions: RSI MRI; Diagnostic Test
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Male only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 4
States / cities: San Diego, California • San Francisco, California • Boston, Massachusetts + 1 more

Conditions: Weight Loss
Interventions: Ideal Protein Weight Loss Method, Standard Weight Loss; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 22 Years to 79 Years
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Bogalusa, Louisiana

Conditions: Overweight and Obesity, Overweight, Obesity
Interventions: Nudge; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Olfaction Disorders, Sinusitis, Paranasal Sinus Diseases
Interventions: Budesonide Respules; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 84 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Breast Cancer, Sentinel Lymph Node, Breast Neoplasms, Breast Cancer Female
Interventions: Lidocaine patch, Buzzy(R), Ice pack; Drug · Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Major Depressive Disorder
Interventions: real-time fMRI neurofeedback: Amygdala, real-time fMRI neurofeedback: HIPS; Behavioral
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Knowledge, Attitude
Interventions: RS+, Codeacademy; Behavioral
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: Up to 17 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Oak Park, Illinois

Conditions: Brain Injury, Concussion
Interventions: Sub-Threshold exercise prescription, Structured stretching prescription; Other
Lead sponsor: University at Buffalo; Other
Eligibility: 10 Years to 18 Years
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Major Depressive Disorder, Alzheimer Disease, Dementia, Nervous System Diseases, Memory Disorders, Depressive Disorder
Interventions: Transcranial direct current stimulation (tDCS); Transcranial alternating current stimulation (tACS); Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight, Obesity
Interventions: Coach Share On, Group Share On, Friend/Family Share On, Coach Share Off, Group Share Off, Friend/Family Share Off, Behavioral Weight Loss Treatment; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 321 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dengue
Interventions: Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC); Biological
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Syracuse, New York

Search by objective public record fields.

A Mixed Methods Evaluation of HPI Resilience Intervention Study

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

Phenytoin for Memory Impairment Secondary to Megestrol

Pain Rating Challenges and Patterns

Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study

House Calls and Peer Mentorship

OTC Hearing Aid and MCI

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)

Lakota Family Acceptance Project

Confronting Unequal Eye Care in Pennsylvania

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss

Precision Public Health: Enhancing Connections to Develop Just-in-Time Adaptive Intervention Strategies

Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases

Testing the Effectiveness of Relationship Smarts and the Effects of Enhanced Facilitator Training

Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion

Home-based Neuromodulation to Target Depression And Memory Symptoms in Older Adults

Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss

Homologous Re-infection With Dengue 1 or Dengue 3